CAMBRIDGE, Mass.--(BUSINESS WIRE)--Javelin Pharmaceuticals, Inc. (NYSE -- Amex: JAV) (“Javelin”) today announced that Hospira, Inc. (“Hospira”) funded a $2 million loan to Javelin on June 10, 2010 under the existing loan agreement between Javelin and Hospira.
